Where does Abiomed Europe GmbH rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Abiomed Europe GmbH ranks #3,952 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Abiomed Europe GmbH hold?

Abiomed Europe GmbH holds 91 US utility patents granted between 2016 and 2025, spanning 13 technology areas.

What is Abiomed Europe GmbH's Innovation Score?

Abiomed Europe GmbH has an Innovation Score of 52.5 out of 100 (top 10% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Abiomed Europe GmbH's patent grant rate increasing or decreasing?

Abiomed Europe GmbH's recent grant velocity is +408% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Abiomed Europe GmbH's patents?

Abiomed Europe GmbH's patents average 18.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Abiomed Europe GmbH patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Abiomed Europe GmbH

Q: What technology areas does Abiomed Europe GmbH focus on?

Abiomed Europe GmbH's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 87 patents, ranking #84 of 3,490 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

USPTO PatentsView assignee record - 91 granted patents across 13 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Abiomed ranks #3,952 of 49,997 tracked US assignees by granted-patent volume, with 91 patents across 13 technology areas.

#3,952
of 49,997 US assignees by volume: Top 10%
by Innovation Score (52.5/100): 18.4
avg claims per patent: +408%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3952 · Foreign Corporation #3,952 · 91 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 91 grants
TOP-DECILE #3,952/49,997
PHOTO-FINISH Agios Pharmaceuticals
CPC-FOCUS A61M · 13 areas
INNOV-PAR 52.5/100
CLAIMS-RICH 18.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +408% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Agios Pharmaceuticals, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Abiomed’s 52.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.6 pts (30%) Velocity 13.0 pts (25%) Breadth 12.7 pts (24%) Claim depth 11.1 pts (21%)

Qualcomm Incorporated · highest

85
Bundesdruckerei · near

52
Woodstream · near

52
Abiomed Europe · this assignee

52
NEC Laboratories… · near

52
Panasonic Liquid… · near

52
3D Lighting… · lowest

7

What this shows Abiomed's Innovation Score is 52.5/100 (top 10% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Abiomed?

Each dot is one of Abiomed’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Abiomed’s own 18.4 claims/patent is ABOVE the 15.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Abiomed vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Abiomed's grants concentrate

Abiomed Europe GmbH is a focused PatentsView assignee: 13 CPC subclasses with 95.6% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2023 (17 grants) versus a trough of 1 in 2019. By volume, Abiomed sits between Veeco Instruments Inc. and Board of Trustees of Southern Illinois University.

Abiomed's three-year grant acceleration

From 2019–2021 to 2022–2024, Abiomed Europe GmbH moved from 21 to 41 grants (1.95x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Veeco Instruments

92
Videojet

92
Watts Regulator

92
Willis Electric

92
Agios Pharmaceuti…

91
Anhui Huami Infor…

91
Azur Space Solar…

91
Board of Trustees…

91
Abiomed Europe ◀

91

What this shows Abiomed holds 91 patents at rank #3,952, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Abiomed

By rank, the assignees closest to #3,952 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Abiomed's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Abiomed, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Abiomed ranks #84 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (52 here).

NEC Laboratories America, Inc. 52 Panasonic Liquid Crystal Display Co., Ltd. 52 Bundesdruckerei GMBH 52 Woodstream Corporation 52

Similar claim depth

Nearest assignees by average claims per patent (18.4 here).

Rosemount Tank Radar AB 18.4 avg Equifax Inc. 18.4 avg Cancer Research Technology Limited 18.4 avg Panasonic Avionics Corporation 18.4 avg

Abiomed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

52 Top 10% higher than 90% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Abiomed Europe GmbH patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	3	3.3%
2017	6	6.6%
2018	2	2.2%
2019	1	1.1%
2020	9	9.9%
2021	11	12.1%
2022	9	9.9%
2023	17	18.7%
2024	15	16.5%
2025partial year	18	19.8%

Which technologies does Abiomed Europe GmbH patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 87

A61B - DIAGNOSIS; SURGERY; Identification 8

F04D - Non-positive-displacement Pumps 6

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 4

H01F - MAGNETS; INDUCTANCES; TRANSFORMERS; Selection OF Materials FOR Their Magnetic Properties 3

F16C - SHAFTS; Flexible SHAFTS; Elements OR Crankshaft MECHANISMS; Rotary Bodies Other Than Gearing ELEMENTS; Bearings 2

H02K - Dynamo-electric Machines 2

B29D - Producing Particular Articles From Plastics OR From Substances IN A Plastic State 1

G01L - Measuring Force, Stress, Torque, Work, Mechanical Power, Mechanical Efficiency, OR Fluid Pressure 1

C23C - Coating Metallic MATERIAL; Coating Material With Metallic MATERIAL; Surface Treatment OF Metallic Material BY Diffusion Into THE Surface, BY Chemical Conversion OR SUBSTITUTION; Coating BY Vacuum Evaporation, BY Sputtering, BY ION Implantation OR BY Chemical Vapour Deposition, IN General 1

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Abiomed Europe GmbH's patent record in context - here's where to go next.

Abiomed Europe GmbH's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 95.6% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #3,952 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Abiomed Europe GmbH against Veeco Instruments Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 52.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.